Daiken Biomedical Co., Ltd. (TPE:7780)

Market Cap	14.42B +58.6%
Revenue (ttm)	2.02B +39.0%
Net Income	337.22M +39.0%
EPS	0.42 -8.6%
Shares Out	810.02M
PE Ratio	42.76
Forward PE	n/a
Dividend	0.70 (3.98%)
Ex-Dividend Date	n/a

Volume	2,465,125
Open	17.50
Previous Close	17.55
Day's Range	17.50 - 17.90
52-Week Range	15.75 - 40.10
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About Daiken Biomedical

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company was founded in 2018 and is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. operates as a subsidiary of Sunfun Info Co., Ltd.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2018
• Employees: 20
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 7780

Financial Performance

In 2025, Daiken Biomedical's revenue was 1.90 billion, an increase of 39.10% compared to the previous year's 1.36 billion. Earnings were 337.87 million, an increase of 217.01%.